TiO


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Jan 2020
Historique:
received: 08 01 2020
revised: 24 01 2020
accepted: 27 01 2020
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 18 11 2020
Statut: epublish

Résumé

Among nanomaterials (NMs), titanium dioxide (TiO

Identifiants

pubmed: 32023866
pii: ijms21030940
doi: 10.3390/ijms21030940
pmc: PMC7037422
pii:
doi:

Substances chimiques

Reactive Oxygen Species 0
titanium dioxide 15FIX9V2JP
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results

Références

Radiother Oncol. 2013 Jul;108(1):136-42
pubmed: 23647757
Annu Rev Pharmacol Toxicol. 2010;50:323-54
pubmed: 20055707
Environ Health Perspect. 2010 Dec;118(12):1699-706
pubmed: 20729176
Eur Rev Med Pharmacol Sci. 2011 May;15(5):481-508
pubmed: 21744743
Nanoscale. 2012 Aug 21;4(16):5043-50
pubmed: 22767269
Nanoscale. 2019 Apr 11;11(15):7025-7040
pubmed: 30920558
Environ Health Perspect. 2011 Nov;119(11):1539-46
pubmed: 21788197
Toxicol Appl Pharmacol. 2012 Jan 15;258(2):226-36
pubmed: 22115978
Nat Rev Drug Discov. 2011 Mar;10(3):221-37
pubmed: 21358741
Nanomedicine (Lond). 2014 May;9(7):1063-82
pubmed: 24978464
Appl Radiat Isot. 2014 Jul;89:25-9
pubmed: 24576993
Lancet Oncol. 2006 Apr;7(4):295-6
pubmed: 16598890
Transl Cancer Res. 2013 Aug;2(4):
pubmed: 24392307
J Food Drug Anal. 2014 Mar;22(1):95-104
pubmed: 24673907
Environ Toxicol Chem. 2015 May;34(5):1070-7
pubmed: 25640001
Inhal Toxicol. 2007;19 Suppl 1:205-12
pubmed: 17886069
Inhal Toxicol. 2007 Aug;19(10):849-56
pubmed: 17687716
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10925-30
pubmed: 9380736
Environ Sci Pollut Res Int. 2019 Feb;26(4):3262-3291
pubmed: 30523526
J Agric Biol Environ Stat. 2011 Jun 1;16(2):221-232
pubmed: 21769246
Eur J Med Chem. 2017 Dec 15;142:163-178
pubmed: 28756878
Environ Sci Technol. 2006 Jul 15;40(14):4346-52
pubmed: 16903269
Biol Trace Elem Res. 2020 Jan;193(1):118-129
pubmed: 30982201
J Nanosci Nanotechnol. 2010 Dec;10(12):8500-7
pubmed: 21121359
ACS Nano. 2012 Jun 26;6(6):5164-73
pubmed: 22587225
Environ Pollut. 2009 Apr;157(4):1127-33
pubmed: 19013699
Chem Biol Interact. 2000 Dec 1;129(1-2):77-97
pubmed: 11154736
Cytometry A. 2010 Jul;77(7):677-85
pubmed: 20564539
Cancer Lett. 2006 May 18;236(2):164-74
pubmed: 15955621
Photochem Photobiol. 2001 Nov;74(5):656-69
pubmed: 11723793
Toxicol Sci. 2005 Dec;88(2):514-24
pubmed: 16177240
Part Fibre Toxicol. 2013 Apr 15;10:15
pubmed: 23587290
Trends Pharmacol Sci. 2018 Jan;39(1):24-48
pubmed: 29224916
Int J Cancer. 2004 May 10;109(6):799-809
pubmed: 15027112

Auteurs

Yidan Wang (Y)

Commissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.

Allan Sauvat (A)

Gustave Roussy, Institut National de la Santé et de la Recherche Médicale, U1138, 94800 Villejuif, France.

Celine Lacrouts (C)

Commissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.

Jérôme Lebeau (J)

Commissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.

Romain Grall (R)

Commissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.

Marie Hullo (M)

Commissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.

Fabrice Nesslany (F)

Laboratoire de Toxicologie Génétique, Institut Pasteur de Lille, Université de Lille, EA 4483, 59000 Lille, France.

Sylvie Chevillard (S)

Commissariat aux Energies Atomique et Alternative, Fundamental Research Division, Jacob Institut, Laboratoire de Cancérologie expérimentale, CEA, F-92265 Fontenay-aux-Roses, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH